Ann: Quarterly Activities Report and Appendix 4C - Dec23, page-6

They still need to engage a NEW US based CMO?

WTH does this mean??????

"......this is aimed to replace the Company’s current IVDD regulatory approvals (CE & CA Mark and Medsafe), which we intend to de-register in February 2024. Further, the Company continues to evaluate various options to participate in the U.S. market, despite FDA regulatory uncertainty"

Shifty as below so they can get mor R&D incentive????? Trying to get the share price up to do a raising later rather than sooner? They want to survive on the smell of an oily rag now? Company is damaged goods.

"formally lodge an amended RDTI claim for its international component of R&D given the current kits reclassification to RUO"

What a joke! " ColoSTAT® in the UK,is deferred until 4Q’FY24"

This company stinks more than ever and it doesn't even have a CEO. It's all FOS.

I could go on and on. Shareholders, just read the announcement over and over. It's truly a disgrace. Treated like fools.